| NDRG1 regulates neutral lipid metabolism in breast cancer cells CJ Sevinsky, F Khan, L Kokabee, A Darehshouri, KR Maddipati, ... Breast Cancer Research 20, 1-17, 2018 | 91 | 2018 |
| A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis C Eifert, X Wang, L Kokabee, A Kourtidis, R Jain, MJ Gerdes, DS Conklin Genes, Chromosomes and Cancer 52 (10), 961-975, 2013 | 72 | 2013 |
| Bruton's tyrosine kinase inhibitors prevent therapeutic escape in breast cancer cells X Wang, J Wong, CJ Sevinsky, L Kokabee, F Khan, Y Sun, DS Conklin Molecular cancer therapeutics 15 (9), 2198-2208, 2016 | 63 | 2016 |
| Bruton's tyrosine kinase is a potential therapeutic target in prostate cancer L Kokabee, X Wang, CJ Sevinsky, WLW Wang, L Cheu, SV Chittur, ... Cancer biology & therapy 16 (11), 1604-1615, 2015 | 53 | 2015 |
| Engineering the cellular protein secretory pathway for enhancement of recombinant tissue plasminogen activator expression in Chinese hamster ovary cells: effects of CERT and … A Rahimpour, B Vaziri, R Moazzami, L Nematollahi, F Barkhordari, ... Journal of microbiology and biotechnology 23 (8), 1116-1122, 2013 | 43 | 2013 |
| Bruton’s tyrosine kinase and its isoforms in cancer X Wang, L Kokabee, M Kokabee, DS Conklin Frontiers in cell and developmental biology 9, 668996, 2021 | 33 | 2021 |
| Bruton's tyrosine kinase as anti-cancer drug target DS Conklin, C Eifert, A Kourtidis, X Wang, L Kokabee US Patent 9,095,592, 2015 | 23 | 2015 |
| Divergent effects of vitamins K1 and K2 on triple negative breast cancer cells S Beaudin, L Kokabee, JE Welsh Oncotarget 10 (23), 2292, 2019 | 17 | 2019 |
| The expression pattern of APC2 and APC7 in various cancer cell lines and AML patients H Rahimi, A Ahmadzadeh, S Yousef-amoli, L Kokabee, MA Shokrgozar, ... Advances in Medical Sciences 60 (2), 259-263, 2015 | 17 | 2015 |
| Thyroid peroxidase gene mutation in patients with congenital hypothyroidism in Isfahan, Iran M Hashemipour, F Soheilipour, S Karimizare, H Khanahmad, ... International journal of endocrinology 2012 (1), 717283, 2012 | 16 | 2012 |
| Evaluation of intron 22 and intron 1 inversions of the factor 8 gene using an inverse shifting PCR method in severe haemophilia A patients N Roozafzay, L Kokabee, S Zeinali, M Karimipoor Sci Asia 39 (2), 174-178, 2013 | 15 | 2013 |
| Metabolic assays for detection of neutral fat stores JM Baumann, L Kokabee, X Wang, Y Sun, J Wong, DS Conklin Bio-protocol 5 (12), e1511-e1511, 2015 | 8 | 2015 |
| Molecular analysis of factor IX gene in an Iranian female with severe hemophilia B M Karimipoor, L Kokabee, E Kamali, SZ Karizi, S Zeinali Acta Haematologica 119 (3), 151-153, 2008 | 6 | 2008 |
| Palmitoylation of the alternative amino terminus of the BTK-C isoform controls subcellular distribution and signaling M Kokabee, X Wang, E Voorand, E Alin, L Kokabee, F Khan, S Desrosiers, ... Cancer Genomics & Proteomics 19 (4), 415-427, 2022 | 5 | 2022 |
| Potential mutations of thyroid peroxidase gene in children with congenital hypothyroidism in Isfahan Province. S Karimizare, F Soheilipour, M Karimipour, K Khanahmad, P Yaghmayee, ... | 4 | 2009 |
| Mutation analysis of coagulation factor IX gene in Esfahanian hemophilia B patients by SSCP and sequencing E Kamali Dolatabadi, M Karimipoor, S Samiee, L Kokabee, S Zinali, ... Scientific Journal of Iran Blood Transfus Organ 3 (4), 299-308, 2007 | 4 | 2007 |
| Analysis of Intron 1 Inversion at F8 gene in severe hemophilia A patients by inverse shifting-PCR referred from Isfahan Seyedolshohada Hospital N Roozafzay, L Kokabee, S Zeinali, M Karimipoor Journal of Ardabil University of Medical Sciences 13 (1), 93-101, 2013 | 3 | 2013 |
| Molecular analysis of coagulation factor IX gene in hemophilia B patients of Khorasan Razavi province NK Karimi, L Kokabee, Z Badiee, M Shahabi, SA Banihashem, S Zeinali, ... Scientific Journal of Iran Blood Transfus Organ 7 (1), 17-26, 2010 | 2 | 2010 |
| Bruton's tyrosine kinase as anti-cancer drug target DS Conklin, C Eifert, A Kourtidis, X Wang, L Kokabee US Patent 9,637,554, 2017 | 1 | 2017 |
| Bruton's Tyrosine Kinase as Anti-Cancer Drug Target DS Conklin, C Eifert, A Kourtipis, L Kokabee, W Xiauhui US Patent App. 17/497,571, 2022 | | 2022 |